Results of clinical trials, which involved the destruction of some inoperable cancerous tumours after direct injection of bacterium, were recently reported in specialist publication Science Translational Medicine.
Though still at an early stage, scientists believe the procedure may be an effective treatment for some inoperable tumours that are resistant to radiotherapy and chemotherapy.
“Our investors can also be proud of their involvement; by investing with us, they are directly helping fund important and potentially life-saving medical research,” said Michael Green, London-based CEO of American Century’s international business.
ACI has $140bn in assets under management and it pays 40% of its annual profits to two medical research institutions as a result of an endowment established by the company’s founder, Jim Stowers.
To date more than $2bn has been paid to fund medical research, the firm said.
A sampling of ACI mutual funds available in Asia:
